Literature DB >> 7043703

Antibiotic resistance of Salmonella in Europe and the United States.

C E Cherubin.   

Abstract

Nontyphoid salmonellosis has been said to be a zoonosis; hence, antibiotic resistance in the salmonella serotypes is thought to be derived directly from resistance in the animal reservoir. This thesis seems incorrect for the following reasons: (1) Typhoid and paratyphoidal salmonellae are clearly exceptions to the rule since they are restricted to human hosts. (2) Salmonella isolates involved in food-borne outbreaks disease have not been notable in terms of their antibiotic resistance. (3) In contrast, outbreaks of nosocomial disease, transmitted from person to person and persisting for long periods, have produced and disseminated multiple resistant salmonellae, such as Salmonella wien (another serotype without an animal reservoir) in western Europe. (4) In western Europe and the United States, there are often large differences between the resistance of isolates from animals and that of isolates from humans. (5) In most reported outbreaks of disease caused by antibiotic-resistant Salmonella in humans or animals, the administration of therapeutic concentrations of antibiotics has been implicated. (6) The role of low-concentration, growth-promoting antibiotic feed supplements has been much discussed but never has been delineated or proven. In fact, these supplements probably are totally irrelevant to the development of antibiotic resistance in Salmonella. With regard to Salmonella, there is an exception to every rule; in this case the exception is Salmonella dublin, which in western Europe is a highly antibiotic-resistant serotype in cattle and appears in humans with a similar--and unusual--pattern of resistance.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7043703     DOI: 10.1093/clinids/3.6.1105

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  13 in total

1.  Antibiotic resistance among Salmonella from human and other sources in New Zealand.

Authors:  H M Heffernan
Journal:  Epidemiol Infect       Date:  1991-02       Impact factor: 2.451

2.  Antimicrobial resistance of Salmonella isolates in a Spanish hospital.

Authors:  P Muńoz; M D Díaz; M Rodríguez-Créixems; E Cercenado; T Peláez; E Bouza
Journal:  Antimicrob Agents Chemother       Date:  1993-05       Impact factor: 5.191

3.  Plasmid-mediated resistance to trimethoprim-sulfamethoxazole in Salmonella krefeld strains isolated in the United States.

Authors:  J J Mathewson; B E Murray
Journal:  Antimicrob Agents Chemother       Date:  1983-03       Impact factor: 5.191

4.  Emergence of multiple drug resistance among Salmonella species in Jordan.

Authors:  A A Shebabi; J Zubi; G Za'balawi
Journal:  Eur J Clin Microbiol       Date:  1985-06       Impact factor: 3.267

5.  Antimicrobial resistance among Salmonella serovars isolated from different sources in Brazil during 1978-1983.

Authors:  L C Campos; E Hofer
Journal:  Antonie Van Leeuwenhoek       Date:  1989-04       Impact factor: 2.271

6.  Salmonella serotypes and incidence of multiply-resistant Salmonellae isolated from diarrhoeal patients in Hong Kong from 1973-82.

Authors:  J Ling; P Y Chau; B Rowe
Journal:  Epidemiol Infect       Date:  1987-10       Impact factor: 2.451

7.  The comparative activity of pefloxacin, enoxacin, ciprofloxacin and 13 other antimicrobial agents against enteropathogenic microorganisms.

Authors:  R Vanhoof; J M Hubrechts; E Roebben; H J Nyssen; E Nulens; J Leger; N De Schepper
Journal:  Infection       Date:  1986 Nov-Dec       Impact factor: 3.553

8.  Invasive Salmonella dublin infections associated with drinking raw milk.

Authors:  J Fierer
Journal:  West J Med       Date:  1983-05

9.  Comparative in vitro activities of aztreonam, ciprofloxacin, norfloxacin, ofloxacin, HR 810 (a new cephalosporin), RU28965 (a new macrolide), and other agents against enteropathogens.

Authors:  H Goossens; P De Mol; H Coignau; J Levy; O Grados; G Ghysels; H Innocent; J P Butzler
Journal:  Antimicrob Agents Chemother       Date:  1985-03       Impact factor: 5.191

10.  Comparative in vitro activity of ceftibuten (Sch 39720) against bacterial enteropathogens.

Authors:  R Shawar; M LaRocco; T G Cleary
Journal:  Antimicrob Agents Chemother       Date:  1989-05       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.